Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Storm Newton

‘Breakthrough’ drug for severe muscle wasting condition set for NHS rollout in England

This decision marks a significant step for families affected by the rare genetic disorder - (PA)

Hundreds of children across England are set to benefit from a new drug which has been approved for rollout on the NHS to treat a severe muscle-wasting condition.

Givinostat is expected to enable eligible patients with Duchenne muscular dystrophy (DMD) to maintain their mobility for longer.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.